Taysha Gene Therapies, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Taysha Gene Therapies, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
  • Taysha Gene Therapies, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Taysha Gene Therapies, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Taysha Gene Therapies, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.